Skip to main content

Table 2 Summary of reported outcomes, out of 31 clinical trials

From: A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials

Trial event

Outcome timing

Outcome timing

During/at the end of treatment [# of studies reporting]

At the end of follow-up [# of studies reporting]

During/at the end of treatment [# of studies reporting]

At the end of follow-up [# of studies reporting]

Favorable outcomes

 

Start with negative culture

 

2

  
 

Defined by one negative culture: “culture negative” at specified time

2

12

  
 

Culture(-) not having been retreated or had tx changed or extended

 

2

  
 

Defined by two negative cultures, with varying intervals between cultures

1

12

  
 

Defined by three negative cultures

2

2

  
 

Defined by all negative cultures in specified time period

 

1

  
 

Inability to produce sputum addressed, with various qualifications

 

10

  
 

No signs/symptoms and can’t produce sputum

 

2

  
 

No signs/symptoms and sputum is contaminated in 2 cultures with no evidence of TB

 

2

  
 

Incomplete culture results but clinical symptoms favorable

 

2

  
 

Relapse-free cure

 

2

  
 

Unfavorable outcomes

Outcome not assessable

Biologically defined

 

Never convert to culture negative

2

1

  
 

Do not have negative status, inconsistent qualifications

 

6

  
 

Persistently positive after specified time

 

1

  
 

Culture positive, confirmed by second (+) sample ≥ 4hr after first (+) culture

 

2

  
 

Two or more (+) cultures at least 1 month apart after 2mos in study and still on tx

2

   
 

Culture positive at end

4

2

  
 

≥ 1 of last two cultures on separate occasions are (+)

 

1

  
 

Culture of ≥20 colonies

1

   
 

≥ 2 (+) cultures in last month, one of which is 20 colonies or more

2

   

Clinical failure at end, regardless of culture

2

5

  

Recurrence: Relapse, varying qualifications

2

29

  

Recurrence: Reinfection with a different strain

 

2

3

13

Death

 

Any cause

5

7

2

2

 

TB-related

11

14

  
 

Death from extra-pulmonary TB

1

   
 

Any non-TB-related death

1

1

4

3

 

Non-TB, except accident, violence, trauma

7

7

9

1

 

Non-TB, except suicide

6

6

3

 
 

Death from a different TB strain

   

1

 

Died with last culture negative

   

5

Withdrawn and lost to follow-up

 

Did not reach endpoint, varying qualifications

 

13

  
 

No culture result at end of FU or last culture contaminated

   

2

 

Culture (+) when last seen

4

4

  
 

Any withdrawal of or loss to follow-up

2

4

2

2

Left study with last culture negative

  

2

7

Treatment issues

 

Extension, with varying exceptions

11

2

  
 

Restart, with varying exceptions

 

11

  
 

Change treatment, with varying exceptions

10

2

  
 

Initiation of treatment for relapse in absence of culture confirmation

 

1

  
 

Change one drug, with varying exceptions

5

3

  
 

Change more than one drug

5

4

  
 

Discontinue treatment, with exceptions

10

  

9

 

Discontinue treatment, due to pregnancy

  

2

 
 

Incomplete, with varying qualifications

5

   
 

Off-protocol drugs

3

3

 

1